Abstract
MANY immune responses are controlled by genes of the major histocompatibility complex (MHC)1. In man these include the loci encoding the HLA-A, -B, -C, -DR, -DQ and -DP antigens, and many diseases have been linked with these2–5. But attempts to identify HLA genes in man that might explain why an immune response against malignant tumours should be ineffective have so far been disappointing, apart from the association reported between the HLA-DR1 antigen and a susceptibility to a rare carcinoma of the thyroid gland6. Here we describe another strong connection between a common malignant tumour and an HLA antigen, namely between HLA-DQw3 and squamous cell carcinoma of the cervix: from the 1988 United States tumour registry, 1 in every 63 newborn girls will develop this invasive cancer7. We found that 88% of 66 patients had the leukocyte antigen HLA-DQw3 when it would normally be expected in only 50% of individuals. In animals the immune system and the MHC act in defence against virally induced tumours, but until now there has been no evidence that they do so in humans8: as squamous cell carcinoma is probably virally induced, our discovery of its association with an HLA antigen will be important to the understanding of the immunogenetic basis of a susceptibility to this tumour.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Klein, J., Juretic, A., Baxevanis, C. N. & Nagy, Z. A. Nature 291, 455–460 (1981).
Schlosstein, L., Terasaki, P. I., Bluestone, R. & Pearson, C. M. New Engl. J. Med. 288, 704–706 (1973).
Brewerton, D. A. et al. Lancet i, 904–907 (1973).
Festenstein, H. Nature 322, 64–67 (1986).
Tiwari, J. L. & Terasaki, P. I. in HLA and Disease Associations (eds Tiwari, J. L. & Terasaki, P. I.) (Springer, New York, 1985).
Panza, N. et al. Tissue Antigens 20, 155–158 (1982).
Barber, H. R. K. in Manual of Gynaecology Oncology (ed. Barber, H. R. K.) 212 (Lippincott, Philadelphia, 1989).
Lachman, P. J. & Mitchison, N. A. in Clinical Aspects of Immunology (eds Lachmann, P. & Peters, K.) 1263–1278 (Blackwell, Oxford, 1982).
Park, M. S., Terasaki, P.I., Bernoco D. & Iwaki J. Transplant. Proc. 10, 823–827 (1978).
Baur, M. P. et al. in Histocompatibility Testing 1984 (eds Albert, E. D. et al.) 333–347 (Springer, Berlin and Heidelberg, 1984).
Kaufmann, J. F., Auffray, C., Kormann, A. J., Skackelford, D. A. & Strominger, J. Cell 36, 1–13 (1984).
Bodmer, W. F. et al. in Immunobiology of HLA Vol. 1 (ed. Dupont, B.) 72–79 (Springer, New York, 1989).
Knowles, R. W. in Immunobiology of HLA Vol. 1 (ed. Dupont, B.) 365–380 (Springer, New York, 1989).
Bodmer, J. G. et al. Tissue Antigens 35, 1–8 (1990).
Vega, M. A., Bragado, R. & Ivanyi, P. J. Immunolology 137, 3557–3565 (1986).
Gissmann, L. & Schneider, A. in Origins of Female Genital Cancer: Virological and Epidemiological aspects (eds zur Hausen, H. & Peto, R.) 217 (Banbury Reports, Cold Spring Harbor Laboratory, New York, 1986).
zur Hausen, H. Lancet ii, 1370–1372 (1982).
Kjaer, S. K. et al., Int. J. Cancer 41, 518–524 (1988).
Kämpgen, E., Burg, G. & Wank, R. Arch. Dermat. 124, 1372–1375 (1988).
Koenig, U. D., Müller, N. & Scheeweis, K. E. Lancet i, 857 (1976).
Lilly, F. & Pincus, T. Adv. Cancer Res. 17, 231–277 (1973).
Chesbro, B. Wehrhy, K. & Stimpfling, J. J. exp. Med. 140, 1457–1467 (1974).
Lonai, P. & Haran-Ghara, N. Immunogenetics 11, 21–29 (1980).
Böyum, A. Scand. J. clin. Lab. Invest. 97, 21–28 (1968).
Julius, M. H., Simpson, E. E. & Herzenberg, L. A. Eur. J. Immunn. 3, 645–648 (1973).
Johnson, J. P. & Wank, R. J. exp. Med. 160, 1350–1359 (1984).
Termijtelen, A. et al. Tissue Antigens 16, 140–146 (1980).
Maeda, H. Tissue Antigens 23, 163–170 (1984).
Tait, B. D. et al. in Immunobiology of HLA Vol. 1 (ed. Dupont, B.) 269–273 Springer, New York, 1989).
Johnson, J. P., Nordwig, H. & Wank, R. Tissue Antigens 29, 26–33 (1987).
Milford, E. L., Park, M. S., Lalouel, J. M. & Kennedy, L. J. in Immunobiology of HLA Vol. 1 (ed. Dupont, B.) 93–106 (Springer, New York, 1989).
Dunn, O. J. J. Amer. statist. Assoc. 54, 52–64 (1961).
Haldane, J. B. S. Ann. hum. Genet 20, 309–311 (1956).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wank, R., Thomssen, C. High risk of squamous cell carcinoma of the cervix for women with HLA-DQw3. Nature 352, 723–725 (1991). https://doi.org/10.1038/352723a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/352723a0
This article is cited by
-
Identifying the HLA DRB1-DQB1 molecules and predicting epitopes associated with high-risk HPV infection clearance and redetection
Scientific Reports (2020)
-
Persistent HPV16/18 infection in Indian women with the A-allele (rs6457617) of HLA-DQB1 and T-allele (rs16944) of IL-1β −511 is associated with development of cervical carcinoma
Cancer Immunology, Immunotherapy (2015)
-
Association of Single Nucleotide Polymorphisms in Tumor Necrosis Factor-Alpha with Cervical Cancer Susceptibility
Cell Biochemistry and Biophysics (2015)
-
HLA-DRB1 Class II antigen level alleles are associated with persistent HPV infection in Mexican women; a pilot study
Infectious Agents and Cancer (2013)
-
BoLA-DRB3 gene polymorphism and FMD resistance or susceptibility in Wanbei cattle
Molecular Biology Reports (2012)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
